Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 30.50
-0.90 (-2.87%)
Apr 17, 2026, 1:30 PM CST
Medigen Biotechnology Revenue
In the year 2025, Medigen Biotechnology had annual revenue of 1.58B TWD with 15.28% growth. Medigen Biotechnology had revenue of 326.68M in the quarter ending December 31, 2025, a decrease of -1.20%.
Revenue
1.58B
Revenue Growth
+15.28%
P/S Ratio
2.68
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.58B | 209.80M | 15.28% |
| Dec 31, 2024 | 1.37B | 214.98M | 18.57% |
| Dec 31, 2023 | 1.16B | 101.77M | 9.64% |
| Dec 31, 2022 | 1.06B | -2.87B | -73.08% |
| Dec 31, 2021 | 3.92B | 3.31B | 537.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genovate Biotechnology | 492.41M |
| Sagittarius Life Science | 346.08M |
| BioGend Therapeutics | 222.34M |
| Pharmosa Biopharm | 67.27M |
| OBI Pharma | 58.58M |
| ACRO Biomedical | 36.50M |
| UnicoCell Biomed | 30.10M |
| Shine-On BioMedical | 30.00M |